Thursday, April 09, 2020 9:05:14 AM
As far as the management team: there doesn't seem to be a lot of trust developed by them towards the 'Street'.
I see two ways to play this... sell into the pop...
Hold for long term...who buys it, or do they transition to a sales team...
Thot of previous trial, they found after it was complete, and a fail that the dosing for 40 minutes was the key.
How did they not indicate a length of dose in the trial protocol?
That is a severely damaging oversight...
I have no medical training, and good thing for the rest of the world.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM